ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 197,67
0,29%
Dow Jones
42 579,08
-0,99%
DAX
23 419,48
1,30%
Brent Oil
69,34
0,00%
Bitcoin
87 490,90
-2,70%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Aridis Pharmaceuticals Inc (ARDS) Cours

Aridis Pharmaceuticals Inc

Aridis Pharmaceuticals Inc (ARDS)

Aridis Pharmaceuticals Inc (CE)
0,289
0,00
(0,00%)
Fermé 07 Mars 10:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,289
Prix Achat
0,218
Prix Vente
0,3007
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
12,882M
Clôture Veille
0,289
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
44 574 021
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-0,68
Chiffre d'affairess
3,09M
Bénéfice net
-30,37M

À propos de Aridis Pharmaceuticals Inc

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.aridispharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-

ARDS Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
29 Juin 2024
ARDS (0,00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
29 Juin 2024
ARDS (0,00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
29 Juin 2024
ARDS (0,00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
29 Juin 2024
ARDS (0,00%)

Form 8-K - Current report
Edgar (US Regulatory)
27 Juin 2024
ARDS (0,00%)

Form 8-K - Current report
Edgar (US Regulatory)
16 Janvier 2024
ARDS (0,00%)

Form 8-K - Current report
Edgar (US Regulatory)
03 Novembre 2023
ARDS (0,00%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ARDS - Frequently Asked Questions (FAQ)

What is the current Aridis Pharmaceuticals share price?
The current share price of Aridis Pharmaceuticals is US$ 0,289
How many Aridis Pharmaceuticals shares are in issue?
Aridis Pharmaceuticals has 44 574 021 shares in issue
What is the market cap of Aridis Pharmaceuticals?
The market capitalisation of Aridis Pharmaceuticals is USD 12,88M
What is the 1 year trading range for Aridis Pharmaceuticals share price?
Aridis Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the cash to sales ratio of Aridis Pharmaceuticals?
The cash to sales ratio of Aridis Pharmaceuticals is 0
What is the reporting currency for Aridis Pharmaceuticals?
Aridis Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Aridis Pharmaceuticals?
The latest annual turnover of Aridis Pharmaceuticals is USD 3,09M
What is the latest annual profit for Aridis Pharmaceuticals?
The latest annual profit of Aridis Pharmaceuticals is USD -30,37M
What is the registered address of Aridis Pharmaceuticals?
The registered address for Aridis Pharmaceuticals is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aridis Pharmaceuticals website address?
The website address for Aridis Pharmaceuticals is www.aridispharma.com
Which industry sector does Aridis Pharmaceuticals operate in?
Aridis Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PSTVPlus Therapeutics Inc
US$ 1,46
(317,14%)
357,55M
AGMHAGM Group Holdings Inc
US$ 0,213
(108,21%)
690,72M
LZMHLZ Technology Holdings Ltd
US$ 9,79
(33,56%)
576,65k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 14,62
(33,39%)
15,92M
GVVisionary Holdings Inc
US$ 4,89
(32,34%)
134,05M
BLNEEastside Distilling Inc
US$ 0,7846
(-89,40%)
12,25k
ACONAclarion Inc
US$ 1,5501
(-77,86%)
51,53M
ELABPMGC Holdings Inc
US$ 0,7132
(-42,02%)
1,51M
SNBRSleep Number Corporation
US$ 7,49
(-41,89%)
4,56M
CCLDCareCloud Inc
US$ 2,0904
(-33,00%)
1,23M
AGMHAGM Group Holdings Inc
US$ 0,213
(108,21%)
694,71M
PSTVPlus Therapeutics Inc
US$ 1,46
(317,14%)
359,59M
NVDANVIDIA Corporation
US$ 110,57
(-5,74%)
321,25M
GVVisionary Holdings Inc
US$ 4,89
(32,34%)
135,24M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,75
(-11,38%)
134,95M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ARDS
Aridis Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces